Back to browse

EXP002258

Paper

Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Combined with Modified TAT Peptide to Enhance BMP-2 Production (2017)

Peptide

mTAT

Sequence: RKKRRQRRRR + 10×His + 2×Cys (C-5H-Tat-5H-C)

RNA

plasmid DNA

All experiment fields

Experiment Id EXP002258
Paper Modification of Human Umbilical Cord Blood Stem Cells Using Polyethylenimine Combined with Modified
Peptide mTAT
Delivery Success Class no
In Vivo Flag no
Uptake Confirmed yes
Label Confidence high
In Vitro Functional Effect yes
Endosomal Escape Evidence
Peptide Concentration variable; optimal mTAT:PEI:DNA = 8:8:1 (w/w)
Rna Concentration 2 µg plasmid per well
Mixing Ratio mTAT:PEI:DNA = 8:8:1 (w/w)
Formulation Format polyplex
Formulation Components mTAT + PEI + plasmid DNA
Size Nm 180.00
Zeta Mv 30.00
Model Scope in_vitro
Model Type in vitro
Cell Lines Or Primary Cells hUCB-MSC
Animal Model
Administration Route cell transfection (4–6 h incubation)
Output Type gene expression (GFP)
Output Value highest GFP-positive fraction vs PEI25 or PEI
Output Units
Output Notes Flow cytometry and fluorescence microscopy show enhanced GFP expression.
Toxicity Notes mTAT/PEI showed significantly lower toxicity than PEI25 (MTT assay).
Curation Notes